Cadeltro 50mg Tablet
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Eltrombopag (50mg)
Overview Cadeltro 50mg Tablet
Eltrombopag 50mg tablets are indicated for the management of low platelet counts stemming from chronic immune thrombocytopenic purpura (ITP) or chronic hepatitis C (HCV). This medication also addresses severe aplastic anemia. Acting as a thrombopoietin receptor agonist, Eltrombopag 50mg stimulates platelet production, thereby improving blood clotting. Adhere strictly to your physician's prescribed dosage and regimen. Administration on an empty stomach is acceptable. Swallow the tablet whole; avoid crushing, chewing, or breaking it. Report any known allergies to your doctor prior to commencing treatment. Commonly reported adverse effects include nausea, vomiting, diarrhea, upper respiratory infections, and urinary tract infections. Consult your doctor if these side effects are troublesome; management strategies may be available. Pre-existing medical conditions and concomitant medications must be disclosed to your doctor before starting this therapy. Dosage modifications might be necessary for individuals with liver impairment.
Primary Ingredients of Cadeltro 50mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Cadeltro 50mg Tablet
Reduced thrombocytes from immune thrombocytopenic purpura or hepatitis C; management of critical bone marrow failure.
Major Benefits of Cadeltro 50mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Cadeltro 50mg Tablet on an empty stomach.
Common Side effects of Cadeltro 50mg Tablet:
- Nausea
- Diarrhea
- Upper respiratory tract infection
- Vomiting
- Increased liver enzymes
- Muscle pain
- Urinary tract infection
How to use Cadeltro 50mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. The Cadeltro 50mg Tablet should be taken on an empty stomach.
How Cadeltro 50mg Tablet works:
Cadeltro 50mg tablets act as a thrombopoietin receptor activator, boosting platelet production within the bloodstream. This increase in platelets helps control and minimize bleeding episodes.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between Cadeltro 50mg Tablet and alcohol is currently undefined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Cadeltro 50mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Cadeltro 50mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Cadeltro 50mg Tablets, which can induce dizziness and reduced alertness, impacting safe operation of a vehicle.
KidneySAFE IF PRESCRIBED
Cadeltro 50mg tablets are considered safe for individuals with kidney disease; dose modification isn't typically necessary. Nevertheless, it's crucial to disclose any kidney condition to your physician. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
For individuals with hepatic impairment, the administration of 50mg Cadeltro tablets requires careful monitoring. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Cadeltro 50mg Tablet :
Omit any missed Cadeltro 50mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Cadeltro 50mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Biphenyl Derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | Thrombopoietin receptor activator |
3,018 People bought this recently